Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aussie Scientists ID Gene That Blocks Main Hepatitis C Drugs In Many

This article was originally published in PharmAsia News

Executive Summary

Australian researchers say they have identified the gene responsible for the lack of the ability of half of Australians infected with hepatitis C to respond to conventional treatment. The Westmead Millenium Institute scientists said the interferon lambda gene has the ability to block the effectiveness of drugs used to treat the chronic infection of liver diseases. About 200,000 Australians have hepatitis C, half of whom fail to respond to the usual treatments. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072743

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel